| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/10/2001 | US6214336 Reducing the fibrinogen level and cholesterol level in blood |
| 04/10/2001 | US6214335 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/10/2001 | US6214334 Integrating postmitotic human nt2n neurons (teratocarcinoma cell line (nt2) neurons) into the spinal cord of a mammal by implanting into the spinal cord |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6213127 Methods for treating cancer using allogeneic lymphocytes without graft vs host disease activity |
| 04/10/2001 | CA2123787C Method of treating non-streptococcal bacterial infections |
| 04/10/2001 | CA2070687C Pharmaceutical preparation for controlling pathogenic intestinal bacteria |
| 04/10/2001 | CA1341212C Osteoinductive factors |
| 04/06/2001 | CA2285161A1 In vitro cultured ligament tissue and method of making same |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023531A1 Recognition of differences in cell cycle structure between stem and differentiated cells |
| 04/05/2001 | WO2001023528A1 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | WO2001023413A1 Extracorporeal endotoxin removal method |
| 04/05/2001 | WO2001023001A2 Rapid peg-modification |
| 04/05/2001 | WO2001022990A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 04/05/2001 | WO2001022979A1 Method to disrupt mitochondrial function |
| 04/05/2001 | WO2001022978A2 Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
| 04/05/2001 | WO2001022976A2 Combination of a statin and ex-vivo treated blood for treating artheroclerosis |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000069455A3 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 04/05/2001 | WO2000066752A3 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide |
| 04/05/2001 | WO2000066713A3 Materials and methods relating to neuronal development |
| 04/05/2001 | WO2000061617A3 Transiently immortalized cells for use in gene therapy |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | DE10021207A1 Stable, orally administered composition comprising dried human maternal milk, useful as baby food, nutritional supplement or carrier for drug administration |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2385327A1 Combined therapies for atherosclerosis treatment |
| 04/05/2001 | CA2384814A1 Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2379623A1 Immunologically significant herpes simplex virus antigens |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same |
| 04/04/2001 | EP1088092A1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 04/04/2001 | EP1088062A1 Transplants for myocardial scars |
| 04/04/2001 | EP1087789A2 Use of poxviruses as enhancer of specific immunity |
| 04/04/2001 | EP1087756A1 Particulate acellular tissue matrix |
| 04/04/2001 | EP0778921B1 Pumping device |
| 04/04/2001 | CN1290303A Use of negative regulation elements for nerve-specific expression of transgenes |
| 04/04/2001 | CN1290178A Transfection particles |
| 04/04/2001 | CN1290175A Live vaccine for human immunodeficiency virus |
| 04/04/2001 | CN1290171A Composition and method for regulating cell proliferation and cell death |
| 04/04/2001 | CN1289618A Health-care polypeptide product for nerve and its preparing process |
| 04/04/2001 | CN1289616A Medicine for treating osteoporosis and its preparing process |
| 04/04/2001 | CN1289612A Inflammation-relieving antalgic medicine and its preparing process |
| 04/04/2001 | CN1289607A Capsule for treating epilepsy |
| 04/04/2001 | CN1289604A Medicine for increasing spermic and helping conception |
| 04/04/2001 | CN1289603A Medicine for nourishing kidney, circulating blood, helping conception and removing spots |
| 04/04/2001 | CN1289598A Veterinary medicine for treating infective serositis of duck and its preparing process |
| 04/04/2001 | CN1064050C Biologic antibiotic peptide, and method for preparing same |
| 04/04/2001 | CN1064049C Thrombopoietin and its producing process |
| 04/04/2001 | CN1063965C Compounded Chinese medicinal preparation for diseases of infants and preparing method thereof |
| 04/04/2001 | CN1063956C Liniment tongibing for cold-type arthralgia |
| 04/04/2001 | CN1063955C Medicinal liquor for treating suppurative bone infection |
| 04/04/2001 | CN1063954C Chinese patent medicine-powder preparation for curing hepatitis B |
| 04/04/2001 | CN1063953C Drug for curing nephrosis and its preparing method |
| 04/04/2001 | CN1063951C Chinese patent drug for curing hepatitis |
| 04/04/2001 | CN1063950C Brain reinforcing ointment |
| 04/04/2001 | CN1063945C External compress paste for discapathy |
| 04/04/2001 | CN1063926C Wood frog ovum composition and its preparation capable of improving calcium absorption function |
| 04/03/2001 | US6211352 Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 04/03/2001 | US6211344 Purifying the starting plasma by immunoadsorption with monoclonal and polyclonal antibodies against factor v to prepare factor v-deficient plasma capable of detecting inactivatable factor v from starting plasma using antibodies |
| 04/03/2001 | US6211164 Sensitization of tumor cells |
| 04/03/2001 | US6211160 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors |
| 04/03/2001 | US6210946 Modified adenovirus containing a fiber replacement protein |
| 04/03/2001 | US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 04/03/2001 | US6210684 Method for delaying the onset of AIDS |
| 04/03/2001 | US6210664 Method for gene transfer to the central nervous system |
| 04/03/2001 | US6210662 Fusion protein having prostatic acid phosphatase (pap) as an n-terminal moiety and gm-csf as a c-terminal moiety, and wherein said cells are effective to activate t-cells to produce a multivalent cytotoxic cellular immune response |
| 04/03/2001 | CA2211120C Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/03/2001 | CA2210823C Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration |
| 03/29/2001 | WO2001022092A2 Method to identify compounds which modulate fra-1 expression fils |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021790A1 Conditional immortalisation of cells |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021767A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/29/2001 | WO2001021766A2 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 03/29/2001 | WO2001021765A2 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 03/29/2001 | WO2001021761A2 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 03/29/2001 | WO2001021220A2 Bioprosthetic heart valves |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021201A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 03/29/2001 | WO2001021200A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | WO2001021184A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | WO2001020999A1 Materials and methods for inducing angiogenesis and the repair of mammalian tissue |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000061742A3 Treatment of cardiac power failure using s100 proteins |
| 03/29/2001 | WO2000058005A3 Immunoadsorber for use in sepsis therapy |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | DE19944858A1 A monoantigen-presenting cell capable of dividing and with suppressed functionality of the co-stimulatory receptors B7 and CD40 |